Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina 27157
20 studies enrolling now · 27 studies all time
What they study most
Acute Myeloid Leukemia, Adolescent Cancer, Astrocytoma, Breast Cancer, COVID-19, Cachexia, Cancer, Cancer Harboring BRAF Alterations, Carcinoma, Non-Small-Cell Lung, Caregiver Distress, Caregiver Social Support, Chemotherapy
Studies at this site
- A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy — Recruiting now
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML) — Recruiting now
- A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
- Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer — Recruiting now
- A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations — Recruiting now
- Metformin Hydrochloride in Combination With Standard of Care Systemic Therapy in Previously Untreated Advanced Unresectable or Metastatic Soft Tissue Sarcoma — Recruiting now
- Assoc. of Genomic Polymorphisms With Cancer Cachexia in Subjects With Panc Adenocarcinoma — Recruiting now
- LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients — Recruiting now
- ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia — Recruiting now
- DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment — Recruiting now
- Assessing and Addressing Health-Related Social Needs Among Families of Children With Cancer — Recruiting now
- Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents — Recruiting now
- A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial — Recruiting now
- A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma — Recruiting now
- Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway — Recruiting now
- Comprehensive Care for AYA: Needs Assessment Survey — Recruiting now
- DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia — Recruiting now
- A Study to Test Different Doses of BI 1831169 Alone and in Combination With an Anti-PD-1 Antibody in People With Different Types of Advanced Cancer (Solid Tumors) — Paused
- Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma — Running, not enrolling
- Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors — Completed
- A Study to Evaluate VXA-CoV2-3.3 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection — Running, not enrolling
- Opioid-Free Pain Control Regimen Following Robotic Radical Prostatectomy — Stopped early
- A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute Lymphoblastic Leukemia (ALL) — Starting soon
- Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients — Running, not enrolling
- Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple Myeloma — Available (expanded access)
- Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients with Recurrent High-Grade Glioma — Running, not enrolling